Download full-text PDF |
Source |
---|
Background: Recruiting large numbers of study participants for Alzheimer's Disease (AD) drug trials remains a significant challenge in need of more effective approaches. Advertising can be an effective way to reach large numbers of prospective participants, but can suffer from low attendance rates. This study examined the relationship between the initial behaviors of prospective AD trial participants who did not attend their first scheduled appointment and their overall likelihood of eventually attending an in-person consultation.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Research Program on Cognition and Neuromodulation-Based Interventions, University of Michigan, Ann Arbor, MI, USA.
Alzheimer's disease and related dementias (ADRD) and its associated care pose unique challenges, particularly within minority groups such as Muslim women. This population may face higher rates of ADRD alongside barriers to accessing culturally sensitive care. This abstract emphasizes the crucial role of understanding and integrating Islamic cultural and religious practices into ADRD care.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Massachusetts Amherst, Amherst, MA, USA.
Community-based organizations (CBOs) are an essential part of dementia service delivery to people living with dementia (PLWD) and family caregivers (CG) impacted by Alzheimer's and other dementias, however use of CBO services particularly by PLWD is limited. Referral of PLWD to CBOs by health systems (HS) and health care providers (HCPs) is a common way that PLWD come to use CBO services, but integration between CBOs and HS/HCPs is inconsistent. For example, referrals to CBOs might come from HS/HCPs or from other CBOs, these referrers might provide referrals for a single program or for multiple different programs, and the referrers might be physicians, social workers, case managers, or other clinicians.
View Article and Find Full Text PDFEur Heart J Open
January 2025
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 63117, USA.
Aims: We aimed to perform a retrospective cohort study using the Centers for Disease Control and Prevention's (CDC's) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database to analyse the trends in cardiovascular disease (CVD)-related mortality in patients with myeloproliferative neoplasms (MPNs) from 1999 to 2020.
Methods And Results: We analysed the death certificate data from the CDC WONDER database from 1999 to 2020 for CVD with co-morbid myeloproliferative disorders in the US population. Age-adjusted mortality rates (AAMRs) and 95% confidence intervals (CIs) were computed per 1 million population by standardizing crude mortality rates to the 2000 US census population.
Clin Kidney J
January 2025
Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
Background: Rates of chronic kidney disease (CKD) may change with ageing populations, rising metabolic and cardiovascular disease prevalence, increasing CKD awareness and new treatments. We examined sex-specific temporal trends in CKD incidence and prevalence from 2011 through 2021.
Methods: We conducted a population-based cohort study among adults residing in the North and Central Denmark Regions (population ∼1.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!